Xencor, Inc.

XNCR Healthcare Biotechnology

Xencor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $125.6 million, up 13.7% from fiscal 2024. In the quarter to June 2026, revenue grew 17.5%, EPS grew 29.3% and free cash flow fell 52.9%, each against the same quarter a year earlier.

25.90 0.74 +2.94%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
3/9
Altman Z
1.73
Beneish M
−2.86
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
599.82 577.60 635.60 675.34 424.37 637.67 558.41 315.73 230.88 141.65
Total non-current assets
275.67 374.34 329.53 170.92 413.84 65.57 111.85 261.01 159.32 286.91
Total Assets
875.50 951.95 965.14 846.27 838.21 703.24 670.25 576.73 390.20 428.56
Total current liabilities
95.91 87.43 73.92 63.84 70.74 121.06 66.56 53.85 72.65 106.29
Total non-current liabilities
144.00 190.49 229.13 54.93 33.97 9.74 10.49 1.20 1.09 8.32
Total liabilities
239.91 277.92 303.05 118.77 104.71 130.80 77.05 55.05 73.74 114.61
Common Equity (Total)
635.59 674.03 662.09 727.50 733.50 572.44 593.20 521.68 316.46 313.95
Shareholders Equity (Total)
635.59 674.03 662.09 727.50 733.50 572.44 593.20 521.68 316.46 313.95
Total Debt
119.75 163.61 189.48 59.63 33.97 11.63 10.73 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates